世界の腎性貧血治療薬市場規模・現状・予測2021-2027

【英語タイトル】Global Renal Anemia Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR4983)・商品コード:QY21APR4983
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:93
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、腎性貧血治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(DS-1093、EPO-018B、FG-2216、JTZ-951、MDGN-201、MMP-0101、その他)、用途別市場規模(病院、研究センター、診療所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・腎性貧血治療薬の市場動向
・企業の競争状況、市場シェア
・腎性貧血治療薬の種類別市場規模(DS-1093、EPO-018B、FG-2216、JTZ-951、MDGN-201、MMP-0101、その他)
・腎性貧血治療薬の用途別市場規模(病院、研究センター、診療所)
・腎性貧血治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・腎性貧血治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・腎性貧血治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・腎性貧血治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・腎性貧血治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bayer AG、BIOCAD、CCM Duopharma Biotech Bhd.、Chong Kun Dang Pharmaceutical Corp.、Daiichi Sankyo Company, Limited、Dong-A Socio Group、Dr. Reddy's Laboratories Limited、Eli Lilly and Company、FibroGen, Inc.、GlaxoSmithKline Plc、Intas Pharmaceuticals Ltd.、Japan Tobacco Inc.、JCR Pharmaceuticals Co., Ltd.、Jiangsu Hansoh Pharmaceutical Co., Ltd.)
・結論
【レポートの概要】

Market Analysis and Insights: Global Renal Anemia Therapeutics Market
The global Renal Anemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Renal Anemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Renal Anemia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Renal Anemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Renal Anemia Therapeutics market.

Global Renal Anemia Therapeutics Scope and Market Size
Renal Anemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Renal Anemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DS-1093
EPO-018B
FG-2216
JTZ-951
MDGN-201
MMP-0101
Others

Segment by Application
Hospital
Research Center
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
BIOCAD
CCM Duopharma Biotech Bhd.
Chong Kun Dang Pharmaceutical Corp.
Daiichi Sankyo Company, Limited
Dong-A Socio Group
Dr. Reddy’s Laboratories Limited
Eli Lilly and Company
FibroGen, Inc.
Chong Kun Dang Pharmaceutical Corp.
Daiichi Sankyo Company, Limited
Japan Tobacco Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Anemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DS-1093
1.2.3 EPO-018B
1.2.4 FG-2216
1.2.5 JTZ-951
1.2.6 MDGN-201
1.2.7 MMP-0101
1.2.8 Others
1.3 Market by Application
1.3.1 Global Renal Anemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Center
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Renal Anemia Therapeutics Market Perspective (2016-2027)
2.2 Renal Anemia Therapeutics Growth Trends by Regions
2.2.1 Renal Anemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Renal Anemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Renal Anemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Renal Anemia Therapeutics Industry Dynamic
2.3.1 Renal Anemia Therapeutics Market Trends
2.3.2 Renal Anemia Therapeutics Market Drivers
2.3.3 Renal Anemia Therapeutics Market Challenges
2.3.4 Renal Anemia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Renal Anemia Therapeutics Players by Revenue
3.1.1 Global Top Renal Anemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Renal Anemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Renal Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Renal Anemia Therapeutics Revenue
3.4 Global Renal Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Renal Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Anemia Therapeutics Revenue in 2020
3.5 Renal Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Renal Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Renal Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Renal Anemia Therapeutics Breakdown Data by Type
4.1 Global Renal Anemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Renal Anemia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Renal Anemia Therapeutics Breakdown Data by Application
5.1 Global Renal Anemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Renal Anemia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Renal Anemia Therapeutics Market Size (2016-2027)
6.2 North America Renal Anemia Therapeutics Market Size by Type
6.2.1 North America Renal Anemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Renal Anemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Renal Anemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Renal Anemia Therapeutics Market Size by Application
6.3.1 North America Renal Anemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Renal Anemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Renal Anemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Renal Anemia Therapeutics Market Size by Country
6.4.1 North America Renal Anemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Renal Anemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Renal Anemia Therapeutics Market Size (2016-2027)
7.2 Europe Renal Anemia Therapeutics Market Size by Type
7.2.1 Europe Renal Anemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Renal Anemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Renal Anemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Renal Anemia Therapeutics Market Size by Application
7.3.1 Europe Renal Anemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Renal Anemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Renal Anemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Renal Anemia Therapeutics Market Size by Country
7.4.1 Europe Renal Anemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Renal Anemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Renal Anemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Renal Anemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Renal Anemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Renal Anemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Renal Anemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Renal Anemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Renal Anemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Renal Anemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Renal Anemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Renal Anemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Renal Anemia Therapeutics Market Size (2016-2027)
9.2 Latin America Renal Anemia Therapeutics Market Size by Type
9.2.1 Latin America Renal Anemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Renal Anemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Renal Anemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Renal Anemia Therapeutics Market Size by Application
9.3.1 Latin America Renal Anemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Renal Anemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Renal Anemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Renal Anemia Therapeutics Market Size by Country
9.4.1 Latin America Renal Anemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Renal Anemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Renal Anemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Renal Anemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Renal Anemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Renal Anemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Renal Anemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Renal Anemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Renal Anemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Renal Anemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Renal Anemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Renal Anemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Renal Anemia Therapeutics Introduction
11.1.4 Bayer AG Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 BIOCAD
11.2.1 BIOCAD Company Details
11.2.2 BIOCAD Business Overview
11.2.3 BIOCAD Renal Anemia Therapeutics Introduction
11.2.4 BIOCAD Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.2.5 BIOCAD Recent Development
11.3 CCM Duopharma Biotech Bhd.
11.3.1 CCM Duopharma Biotech Bhd. Company Details
11.3.2 CCM Duopharma Biotech Bhd. Business Overview
11.3.3 CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Introduction
11.3.4 CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.3.5 CCM Duopharma Biotech Bhd. Recent Development
11.4 Chong Kun Dang Pharmaceutical Corp.
11.4.1 Chong Kun Dang Pharmaceutical Corp. Company Details
11.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
11.4.3 Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Introduction
11.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
11.5 Daiichi Sankyo Company, Limited
11.5.1 Daiichi Sankyo Company, Limited Company Details
11.5.2 Daiichi Sankyo Company, Limited Business Overview
11.5.3 Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Introduction
11.5.4 Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.5.5 Daiichi Sankyo Company, Limited Recent Development
11.6 Dong-A Socio Group
11.6.1 Dong-A Socio Group Company Details
11.6.2 Dong-A Socio Group Business Overview
11.6.3 Dong-A Socio Group Renal Anemia Therapeutics Introduction
11.6.4 Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.6.5 Dong-A Socio Group Recent Development
11.7 Dr. Reddy’s Laboratories Limited
11.7.1 Dr. Reddy’s Laboratories Limited Company Details
11.7.2 Dr. Reddy’s Laboratories Limited Business Overview
11.7.3 Dr. Reddy’s Laboratories Limited Renal Anemia Therapeutics Introduction
11.7.4 Dr. Reddy’s Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.7.5 Dr. Reddy’s Laboratories Limited Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Renal Anemia Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 FibroGen, Inc.
11.9.1 FibroGen, Inc. Company Details
11.9.2 FibroGen, Inc. Business Overview
11.9.3 FibroGen, Inc. Renal Anemia Therapeutics Introduction
11.9.4 FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.9.5 FibroGen, Inc. Recent Development
11.10 GlaxoSmithKline Plc
11.10.1 GlaxoSmithKline Plc Company Details
11.10.2 GlaxoSmithKline Plc Business Overview
11.10.3 GlaxoSmithKline Plc Renal Anemia Therapeutics Introduction
11.10.4 GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.10.5 GlaxoSmithKline Plc Recent Development
11.11 Intas Pharmaceuticals Ltd.
11.11.1 Intas Pharmaceuticals Ltd. Company Details
11.11.2 Intas Pharmaceuticals Ltd. Business Overview
11.11.3 Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Introduction
11.11.4 Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.11.5 Intas Pharmaceuticals Ltd. Recent Development
11.12 Japan Tobacco Inc.
11.12.1 Japan Tobacco Inc. Company Details
11.12.2 Japan Tobacco Inc. Business Overview
11.12.3 Japan Tobacco Inc. Renal Anemia Therapeutics Introduction
11.12.4 Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.12.5 Japan Tobacco Inc. Recent Development
11.13 JCR Pharmaceuticals Co., Ltd.
11.13.1 JCR Pharmaceuticals Co., Ltd. Company Details
11.13.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.13.3 JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Introduction
11.13.4 JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.13.5 JCR Pharmaceuticals Co., Ltd. Recent Development
11.14 Jiangsu Hansoh Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Details
11.14.2 Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview
11.14.3 Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Introduction
11.14.4 Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2016-2021)
11.14.5 Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Renal Anemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DS-1093
Table 3. Key Players of EPO-018B
Table 4. Key Players of FG-2216
Table 5. Key Players of JTZ-951
Table 6. Key Players of MDGN-201
Table 7. Key Players of MMP-0101
Table 8. Key Players of Others
Table 9. Global Renal Anemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Renal Anemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Renal Anemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Renal Anemia Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Renal Anemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Renal Anemia Therapeutics Market Share by Regions (2022-2027)
Table 15. Renal Anemia Therapeutics Market Trends
Table 16. Renal Anemia Therapeutics Market Drivers
Table 17. Renal Anemia Therapeutics Market Challenges
Table 18. Renal Anemia Therapeutics Market Restraints
Table 19. Global Renal Anemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Renal Anemia Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Anemia Therapeutics as of 2020)
Table 22. Ranking of Global Top Renal Anemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Renal Anemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Renal Anemia Therapeutics Product Solution and Service
Table 26. Date of Enter into Renal Anemia Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Renal Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Renal Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Renal Anemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Renal Anemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Renal Anemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Renal Anemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Renal Anemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Renal Anemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Renal Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Renal Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Renal Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Renal Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Renal Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Renal Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Renal Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Renal Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Renal Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Renal Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Renal Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Renal Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Renal Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Renal Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Renal Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Renal Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Renal Anemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Renal Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Renal Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Renal Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Renal Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Renal Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Renal Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Renal Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Renal Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Renal Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Renal Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Renal Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Renal Anemia Therapeutics Product
Table 69. Bayer AG Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. BIOCAD Company Details
Table 72. BIOCAD Business Overview
Table 73. BIOCAD Renal Anemia Therapeutics Product
Table 74. BIOCAD Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 75. BIOCAD Recent Development
Table 76. CCM Duopharma Biotech Bhd. Company Details
Table 77. CCM Duopharma Biotech Bhd. Business Overview
Table 78. CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Product
Table 79. CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 80. CCM Duopharma Biotech Bhd. Recent Development
Table 81. Chong Kun Dang Pharmaceutical Corp. Company Details
Table 82. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 83. Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Product
Table 84. Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 86. Daiichi Sankyo Company, Limited Company Details
Table 87. Daiichi Sankyo Company, Limited Business Overview
Table 88. Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Product
Table 89. Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Daiichi Sankyo Company, Limited Recent Development
Table 91. Dong-A Socio Group Company Details
Table 92. Dong-A Socio Group Business Overview
Table 93. Dong-A Socio Group Renal Anemia Therapeutics Product
Table 94. Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Dong-A Socio Group Recent Development
Table 96. Dr. Reddy's Laboratories Limited Company Details
Table 97. Dr. Reddy's Laboratories Limited Business Overview
Table 98. Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Product
Table 99. Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Dr. Reddy's Laboratories Limited Recent Development
Table 101. Eli Lilly and Company Company Details
Table 102. Eli Lilly and Company Business Overview
Table 103. Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Eli Lilly and Company Recent Development
Table 105. FibroGen, Inc. Company Details
Table 106. FibroGen, Inc. Business Overview
Table 107. FibroGen, Inc. Renal Anemia Therapeutics Product
Table 108. FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 109. FibroGen, Inc. Recent Development
Table 110. GlaxoSmithKline Plc Company Details
Table 111. GlaxoSmithKline Plc Business Overview
Table 112. GlaxoSmithKline Plc Renal Anemia Therapeutics Product
Table 113. GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 114. GlaxoSmithKline Plc Recent Development
Table 115. Intas Pharmaceuticals Ltd. Company Details
Table 116. Intas Pharmaceuticals Ltd. Business Overview
Table 117. Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Product
Table 118. Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Intas Pharmaceuticals Ltd. Recent Development
Table 120. Japan Tobacco Inc. Company Details
Table 121. Japan Tobacco Inc. Business Overview
Table 122. Japan Tobacco Inc. Renal Anemia Therapeutics Product
Table 123. Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Japan Tobacco Inc. Recent Development
Table 125. JCR Pharmaceuticals Co., Ltd. Company Details
Table 126. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 127. JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Product
Table 128. JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 129. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 130. Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Details
Table 131. Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview
Table 132. Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Product
Table 133. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Anemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. DS-1093 Features
Figure 3. EPO-018B Features
Figure 4. FG-2216 Features
Figure 5. JTZ-951 Features
Figure 6. MDGN-201 Features
Figure 7. MMP-0101 Features
Figure 8. Others Features
Figure 9. Global Renal Anemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Research Center Case Studies
Figure 12. Clinic Case Studies
Figure 13. Renal Anemia Therapeutics Report Years Considered
Figure 14. Global Renal Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Renal Anemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Renal Anemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Renal Anemia Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Renal Anemia Therapeutics Market Share by Players in 2020
Figure 19. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Anemia Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Renal Anemia Therapeutics Revenue in 2020
Figure 21. Global Renal Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Renal Anemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Renal Anemia Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Renal Anemia Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Renal Anemia Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Renal Anemia Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Renal Anemia Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Renal Anemia Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Renal Anemia Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Renal Anemia Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Renal Anemia Therapeutics Market Share by Region (2016-2027)
Figure 43. China Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Renal Anemia Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Renal Anemia Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Renal Anemia Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Renal Anemia Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Renal Anemia Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Renal Anemia Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Renal Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Bayer AG Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 63. BIOCAD Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 64. CCM Duopharma Biotech Bhd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 65. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 66. Daiichi Sankyo Company, Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 67. Dong-A Socio Group Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 68. Dr. Reddy's Laboratories Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 69. Eli Lilly and Company Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 70. FibroGen, Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 71. GlaxoSmithKline Plc Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 72. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 73. Japan Tobacco Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 74. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 75. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed


【掲載企業】

Bayer AG、BIOCAD、CCM Duopharma Biotech Bhd.、Chong Kun Dang Pharmaceutical Corp.、Daiichi Sankyo Company, Limited、Dong-A Socio Group、Dr. Reddy's Laboratories Limited、Eli Lilly and Company、FibroGen, Inc.、GlaxoSmithKline Plc、Intas Pharmaceuticals Ltd.、Japan Tobacco Inc.、JCR Pharmaceuticals Co., Ltd.、Jiangsu Hansoh Pharmaceutical Co., Ltd.

★調査レポート[世界の腎性貧血治療薬市場規模・現状・予測2021-2027] (コード:QY21APR4983)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腎性貧血治療薬市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆